2017-01807. Program-Specific Guidance About Medical Use Licenses  

  • Start Preamble

    AGENCY:

    Nuclear Regulatory Commission.

    Start Printed Page 8546

    ACTION:

    Draft NUREG; extension of comment period.

    SUMMARY:

    On December 6, 2016, the U.S. Nuclear Regulatory Commission (NRC) solicited comments on draft NUREG-1556, Volume 9, Revision 3, “Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Medical Use Licenses.” The public comment period was originally scheduled to close on February 6, 2017. The NRC has decided to extend the public comment period to allow more time for members of the public to develop and submit their comments.

    DATES:

    The due date of comments requested in the document published on December 6, 2016 (81 FR 87978) is extended. Comments should be filed no later than March 31, 2017. Comments received after this date will be considered if it is practical to do so, but the NRC is able to ensure consideration only for comments received on or before this date.

    ADDRESSES:

    You may submit comments by any of the following methods (unless this document describes a different method for submitting comments on a specific subject):

    • Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2016-0122. Address questions about NRC dockets to Carol Gallagher; telephone: 301-415-3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document.
    • Mail comments to: Cindy Bladey, Office of Administration, Mail Stop: OWFN-12-H08, U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001.

    For additional direction on accessing information and submitting comments, see “Obtaining Information and Submitting Comments” in the SUPPLEMENTARY INFORMATION section of this document.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Katie Tapp, Office of Nuclear Material Safety and Safeguards; U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001; telephone: 301-415-0236; email: Katherine.Tapp@nrc.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    I. Obtaining Information and Submitting Comments

    A. Obtaining Information

    Please refer to Docket ID NRC-2016-0122 when contacting the NRC about the availability of information regarding this document. You may obtain publicly-available information related to this action by the following methods:

    • Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2016-0122.
    • NRC's Agencywide Documents Access and Management System (ADAMS): You may obtain publicly-available documents online in the ADAMS Public Documents collection at http://www.nrc.gov/​reading-rm/​adams.html. To begin the search, select “ADAMS Public Documents” and then select “Begin Web-based ADAMS Search.” For problems with ADAMS, please contact the NRC's Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or by email to pdr.resource@nrc.gov. The draft NUREG-1556, Volume 9, Revision 3, is available in ADAMS under Accession No. ML16328A214.
    • NRC's PDR: You may examine and purchase copies of public documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852.

    The draft NUREG-1556, Volume 9, Revision 3, is also available on the NRC's public Web site on: (1) The “Consolidated Guidance About Materials Licenses (NUREG-1556)” page at http://www.nrc.gov/​reading-rm/​doc-collections/​nuregs/​staff/​sr1556/;;; and (2) the “Draft NUREG-Series Publications for Comment” page at http://www.nrc.gov/​public-involve/​doc-comment.html#nuregs.

    B. Submitting Comments

    Please include Docket ID NRC-2016-0122 in the subject line of your comment submission, in order to ensure that the NRC is able to make your comment submission available to the public in this docket.

    The NRC cautions you not to include identifying or contact information that you do not want publicly disclosed in your comment submission. The NRC will post all comment submissions at http://www.regulations.gov and enter the comment submissions into ADAMS, but the NRC does not routinely edit comment submissions to remove identifying or contact information.

    If you are requesting or aggregating comments from other persons for submission to the NRC, you should inform these persons that they should not include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment submissions into ADAMS.

    II. Discussion

    On December 6, 2016, the NRC solicited comments on draft NUREG-1556, Volume 9, Revision 3, “Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Medical Use Licenses.”

    The purpose of the document published on December 6, 2016 (81 FR 87978) was to provide the public an opportunity to review and comment on draft NUREG-1556, Volume 9, Revision 3. The NUREG provides guidance to existing medical use of byproduct material licensees and to an applicant that are preparing a medical use of byproduct material license application. The NUREG also provides the NRC criteria for evaluating a license application.

    The public comment period was originally scheduled to close on February 6, 2017. The NRC has decided to extend the public comment period on this document until March 31, 2017, to allow more time for members of the public to submit their comments.

    Dated at Rockville, Maryland, this 18th day of January 2017.

    For the U.S. Nuclear Regulatory Commission.

    Daniel S. Collins,

    Director, Division of Material Safety, State, Tribal and Rulemaking Programs, Office of Nuclear Material Safety and Safeguards.

    The public comment period was originally scheduled to close on February 6, 2017. The NRC has decided to extend the public comment period on this document until March 31, 2017, to allow more time for members of the public to submit their comments.

    Start Signature

    Dated at Rockville, Maryland, this 18th day of January 2017.

    For the U.S. Nuclear Regulatory Commission.

    Daniel S. Collins,

    Director, Division of Material Safety, State, Tribal and Rulemaking Programs, Office of Nuclear Material Safety and Safeguards.

    End Signature Start Printed Page 8547

    ML17017A419

    OFCMSTR/MSEBMSTR/MSLBMSTR/MSLBMSTR
    NAMEAMcMurtray for KTappAMcMurtrayHGonzalezDCollins
    DATE1/18/171/18/171/18/171/18/17

    Official Record Copy

    End Supplemental Information

    [FR Doc. 2017-01807 Filed 1-25-17; 8:45 am]

    BILLING CODE 7590-01-P

Document Information

Published:
01/26/2017
Department:
Nuclear Regulatory Commission
Entry Type:
Notice
Action:
Draft NUREG; extension of comment period.
Document Number:
2017-01807
Dates:
The due date of comments requested in the document published on December 6, 2016 (81 FR 87978) is extended. Comments should be filed no later than March 31, 2017. Comments received after this date will be considered if it is practical to do so, but the NRC is able to ensure consideration only for comments received on or before this date.
Pages:
8545-8547 (3 pages)
Docket Numbers:
NRC-2016-0122
PDF File:
2017-01807.Pdf
Supporting Documents:
» Consolidated Guidance About Material Licenses - Program-Specific Guidance About Medical Use Licenses (NUREG-1556, Volume 9, Revision 3)